Lippincott ^® NursingCenter ^®

Featured Articles

• Free

  Decreased Prostate Cancer Risk Found Again with Selenium

  Robert H. Carlson

• Buy

  DLBCL: CT Surveillance Adds Little Value in Detecting Relapse

  Robert H. Carlson

• Buy

  Exercise, Estrogen, and Breast Cancer Risk Mixed Outcomes in Recent Studies

  Rabiya S. Tuma PhD

• Free

  FDA Approves Two Drugs for Advanced Melanoma—Tafinlar and Mekinist—and Companion Diagnostic
• Buy

  For Advanced Patients with Advanced NSCLC, 60 Gy Dose for Radiation Therapy Still the Standard

  Robert H. Carlson

• Buy

  How Do I Treat Patients with Advanced HER2-Positive Breast Cancer?

  Edith A. Perez MD

• Buy

  Immunotherapy Poised to Change ‘Treatment Paradigm’ in Melanoma, Other Solid Tumors

  Rabiya S. Tuma PhD

• Buy

  In Early Research, CLL Patients Appear to Benefit from Isoform-Specific PI3K Inhibitor

  Rabiya S. Tuma PhD

• Buy

  In Younger Adults with Advanced Cancer, Stronger Alliance Leads to Better Compliance, Enhanced Well-Being

  Robert H. Carlson

• Buy

  Leukemia Researcher Describes 10-Year Personal Battle against Adult ALL

  Mark Fuerst

• Buy

  Lung Cancer European Multidisciplinary Meeting Spotlights Progress in Molecularly Guided Therapy

  Peter Goodwin

• Buy

  Men's Cardiorespiratory Fitness at 50 Shown to Predict Cancer Mortality Later in Life

  Rabiya S. Tuma PhD

• Buy

  Oncology Drug Shortage Update Study Documents Cancer Drug Shortages Have Occurred Often, Led to Treatment Delays, Increased the Risk of Errors, Complicated Research, & Increased Costs

  Heather Lindsey

• Buy

  Opting Out of Adjuvant Therapy Safe for Most Men with Seminoma

  Robert H. Carlson

• Buy

  Science Symposium for ACS's 100th Anniversary Spotlights Cancer Progress, Disappointments, & Goals

  Peggy Eastman